Letters, Testimony & Comments

November 14, 2002
On October 17, 2002, Judge Henry H. Kennedy of the U.S. District Court for District of Columbia struck down FDA's "pediatric rule." Among other things, the rule allowed FDA to require that drug and biologics applications "...
November 6, 2002
Carl B. Feldbaum, BIO President Since its inception in the 1970's, the biotechnology industry's mission has been to improve and save human lives. The industry has followed through on that commitment with more than 120 new drugs and...
October 24, 2002
The Honorable Mitchell E. Daniels, Jr. Director, Office of Management and Budget Dwight D. Eisenhower Executive Office Building, #252 17th Street and Pennsylvania Avenue, N.W. Washington, D.C. 20503 Dear Director Daniels: We are writing to...
October 4, 2002
Dear Governor Kitzhaber: This letter explains why FDA objects to the pending ballot initiative to require the mandatory labeling of foods and food additives produced using genetic engineering sold in Oregon, or produced in Oregon and shipped to...
October 4, 2002
Sent to Governor Kitzhaber (October 4, 2002).
October 2, 2002
Dear Senator Daschle: The Biotechnology Industry Organization (BIO) strongly supports the Conference Agreement on the Department of Justice Authorization Act (HR 2215) and urges passage by the U.S. Senate. The House of Representatives passed the...
September 20, 2002
Letter from BIO to the U.S. House of Representatives strongly urging members not to sign the discharge petition (H. Res. 517) offered by the Democratic leadership that would bring the "Greater Access to Affordable Pharmaceuticals Act of 2001...
August 8, 2002
BIO members should immediately become familiar with provisions of the Public Health Security and Bioterrorism Response Act of 2002 (Pub. L. No. 107-188) that require facilities in possession of select agents or high consequence livestock pathogens...
July 15, 2002
Expressing strong concerns regarding S. 812 (McCain/Schumer- Edwards/Collins)
June 14, 2002
Dear Majority Leader Daschle:      The Biotechnology Industry Organization (BIO) opposes Senator Brownback's patent amendment to S. 2600, the Terrorism Risk Insurance Act of 2002, now under consideration by the U.S....
June 14, 2002
Dear Senator Hatch:      I read in the Washington Post that Senators are considering a two-year moratorium on somatic cell nuclear transfer (SCNT). On behalf of the Biotechnology Industry Organization (BIO), an...
June 14, 2002
The Honorable Thomas A. Daschle 509 Hart Senate Office Building Washington, DC 20510 Dear Majority Leader Daschle:      The Biotechnology Industry Organization (BIO) opposes Senator Brownback's patent amendment...
June 4, 2002
Letter from HHS Secretary Tommy Thompson